Oki, E., Makiyama, A., Miyamoto, Y., Kotaka, M., Kawanaka, H., Miwa, K., . . . Mori, M. (2020). Trifluridine/tipiracil plus bevacizumab as a first‐line treatment for elderly patients with metastatic colorectal cancer (KSCC1602): A multicenter phase II trial. Cancer Med.
Styl ChicagoOki, Eiji, et al. "Trifluridine/tipiracil Plus Bevacizumab As a First‐line Treatment for Elderly Patients With Metastatic Colorectal Cancer (KSCC1602): A Multicenter Phase II Trial." Cancer Med 2020.
Citace podle MLAOki, Eiji, et al. "Trifluridine/tipiracil Plus Bevacizumab As a First‐line Treatment for Elderly Patients With Metastatic Colorectal Cancer (KSCC1602): A Multicenter Phase II Trial." Cancer Med 2020.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..